Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Ranks among the top five percent of all participating companies in the industry.
January 20, 2023
By: Charlie Sternberg
Vetter, a contract development and manufacturing organization (CDMO), achieved gold status in the independent EcoVadis sustainability ranking. With 72 points out of a maximum of 100, the pharmaceutical service provider significantly increased its score compared to the last evaluation and is now among the top five percent of all participating companies in the industry. Sustainability plays an important role at Vetter and has been deeply rooted in its corporate strategy for many years. The positive result reaffirms the ongoing commitment and demonstrates where the family-owned company is implementing improvements in the rating criteria of Environment, Labour & Human Rights, Ethics and Sustainable Procurement. The applied methodology is based on international CSR standards such as the Global Reporting Initiative, the United Nations Global Compact, and ISO 26000. “Tens of thousands of companies around the world, including many of our customers, use EcoVadis as an indicator of sustainable business practices. They also incorporate the independent assessments into their selection of suppliers and business partners,” explains Henryk Badack, Vetter’s Senior Vice President Technical Service/Internal Project Management. “We are very proud that our far-reaching initiatives in many areas around sustainable corporate governance have had a significant impact on the EcoVadis rating, and that we were, once again, able to demonstrate improvement over previous years. The positive external evaluation is a strong achievement and further motivates us to continue this great development in a transparent manner among our employees, customers, and partners, as well as the patients and society,” said Vetter Managing Director Peter Soelkner.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !